Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare study.
Debra A GoldmanAnne S ReinerEli L DiamondLisa M DeAngelisViviane TabarKatherine S PanageasPublished in: Neuro-oncology advances (2020)
Re-resection rates were low among elderly GBM patients, and no survival advantage was observed for patients who underwent re-resection. However, patients who received standard of care at initial diagnosis had a lower risk of death. Older adults benefit from receiving radiation + temozolomide after initial resection, and future studies should assess the relationship between re-resection and OS taking the time of re-resection into account.